[Tactics of treating children with Coat's disease]

Insights

This study on Coats disease in 50 children found that treatments like laser coagulation and cryotherapy achieved stable anatomic results in 97% of eyes. Visual acuity was preserved in over 87% of patients, offering hope for vision retention.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Retinal Diseases

Context:

  • Coats disease is a rare condition affecting retinal vasculature.
  • Understanding the disease's progression through distinct stages is crucial for effective management.
  • Early and aggressive treatment is often necessary to prevent vision loss.

Purpose:

  • To evaluate the efficacy of combined therapeutic interventions for Coats disease in children.
  • To assess the long-term anatomic and visual outcomes following treatment.

Summary:

  • Fifty children diagnosed with Coats disease, ranging from 2 months to 12 years old, were analyzed.
  • A cohort of 32 children (33 eyes) underwent treatment involving retinal argon laser coagulation, cryotherapy, scleral buckling, and subretinal fluid drainage.
  • The study identified four distinct stages of Coats disease: initial, moderate, advanced, and terminal.

Impact:

  • Treatment resulted in stable anatomic outcomes in 97% of affected eyes.
  • A significant majority of children (87.9%) retained a visual acuity of at least 0.02.
  • These findings support the effectiveness of multimodal treatment strategies in preserving vision for children with Coats disease.

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...